Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy Tata Power at Rs. 56/ share 1 year before?

SMS Pharmaceuticals informs about outcome of board meeting

07 Aug 2021

SMS Pharmaceuticals has informed that Board of Directors of the Company at their meeting held on today considered and approved the: Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report, Reclassification of promoter group shareholding from promoter category to public category, Directors Report by the Board for the FY 2020-21, Convening the 33rd Annual General Meeting on 30th, September, 2021 and Dividend Distribution Policy. Accordingly, the company has enclosed the following: Reclassification of Promoter group shareholding from promoter category to public category and Standalone and Consolidated un-audited Financial Results for the quarter ended 30th June, 2021 along with the Limited Review Report. The meeting commenced at 10.30 am and concluded at 12.30 pm.

The above information is a part of company’s filings submitted to BSE.

Related SMS Pharmaceuticals Ltd. Links:

SMS Pharmaceuticals Share Price

148.80 0.65 (0.44%) Oct 19, 17:29
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 827.35
Cipla 906.20
Dr. Reddy's Lab 4800.45
Aurobindo Pharma 713.20
Lupin 938.95
View more..
Sensex vs SMS Pharmaceuticals
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback